Market Overview

UPDATE: Goldman Sachs Resumes Coverage on Jabil Circuit on Weaker Growth, Reasonable Valuation

Related JBL
Daily Movers: Welcoming Fitbit; BioMarin Soars Again, While Oracle Slumps
Mid-Afternoon Market Update: BioMarin Pharmaceutical Jumps Following Announcement Of Positive BMN 111 Data; Jabil Circuit Shares Fall

In a report published Wednesday, Goldman Sachs analyst Mark Delaney resumed coverage on Jabil Circuit (NYSE: JBL) with a Neutral rating and $22.00 price target.

In the report, Goldman Sachs noted, “We expect Jabil's fundamentals to be pressured over the next few quarters as it substantially ends its business with Blackberry (12% of revenue in FY12). In addition, we are concerned that Jabil has lost share even excluding Blackberry, as (1) Jabil's revenue outside of Apple has declined in each of the last two years (Exhibit 89) and (2) Jabil's Healthcare segment revenue has declined yoy for five straight quarters while Plexus' Healthcare revenue has grown yoy for five straight quarters. These risks are mitigated in our view by the fact that: (1) Jabil guided FY14 EPS assuming minimal Blackberry revenue, which we believe will help to appropriately set investor expectations for this business; (2) Handset assembly business, which we believe was the majority of Jabil's Blackberry business, is a low margin business. If Jabil is able to restructure/fill its unutilized equipment, structural margins could be higher. (3) Jabil's revenue in the November quarter will likely benefit as Apple (19% of revenue in FY13) ramps the new iPhone. (4) Jabil is the worst performing EMS stock YTD, up 14% vs. the group average up 43%.”

Jabil Circuit closed on Tuesday at $21.90.

Latest Ratings for JBL

Jun 2015NeedhamUpgradesHoldBuy
Jun 2015RBC CapitalMaintainsSector Perform
Jun 2015RBC CapitalMaintainsSell

View More Analyst Ratings for JBL
View the Latest Analyst Ratings

Posted-In: Goldman Sachs Mark DelaneyAnalyst Color Initiation Analyst Ratings


Related Articles (JBL)

Around the Web, We're Loving...

Get Benzinga's Newsletters